U.S. Physical Therapy (DB:UPH) - Aandelenkoers, Nieuws & Analyse

UPH Overzicht aandelen

U.S. Physical Therapy, Inc. heeft poliklinieken voor fysiotherapie. Meer informatie

UPH fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	4/6
Prestaties in het verleden	0/6
Financiële gezondheid	4/6
Dividenden	3/6

Beloningen

Verhandeld tegen 45.7% onder onze schatting van de reële waarde

De winst zal naar verwachting met 29.37% per jaar groeien

Risicoanalyse

Grote eenmalige posten die de financiële resultaten beïnvloeden

Winstmarges (2.2%) zijn lager dan vorig jaar (4.1%)

Dividend van 1.8% wordt niet goed gedekt door de winst

Aanzienlijke insider-verkoop in de afgelopen 3 maanden

U.S. Physical Therapy, Inc. Concurrenten

RHÖN-KLINIKUM

XTRA:RHK

€836.7m

M1 Kliniken

XTRA:M12

€307.1m

LIMES Schlosskliniken

XTRA:LIK

€99.7m

Gesundheitswelt Chiemgau

MUN:JTH

€24.4m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor U.S. Physical Therapy
Historische aandelenkoersen
Huidige aandelenkoers	US$89.50
52 Week Hoogtepunt	US$104.00
52 Week Laag	US$69.50
Bèta	1.39
11 maand verandering	19.33%
3 maanden verandering	20.13%
1 Jaar Verandering	11.88%
33 jaar verandering	13.29%
5 jaar verandering	-15.57%
Verandering sinds IPO	590.59%

Recent nieuws en updates

Recent updates

Rendement voor aandeelhouders

	UPH	DE Healthcare	DE Markt
7D	7.2%	1.1%	0.2%
1Y	11.9%	16.5%	8.5%

Rendement versus industrie: UPH presteerde slechter dan de German Healthcare -sector, die het afgelopen jaar een rendement van 16.5 % opleverde.

Rendement versus markt: UPH overtrof de German markt, die het afgelopen jaar een rendement opleverde van 8.5 %.

Prijsvolatiliteit

Is UPH's price volatile compared to industry and market?
UPH volatility
UPH Average Weekly Movement	5.5%
Healthcare Industry Average Movement	4.1%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.3%

Stabiele aandelenkoers: UPH heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van UPH is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1990	5,310	Chris Reading	www.usph.com

U.S. Physical Therapy, Inc. exploiteert poliklinieken voor fysiotherapie. Het bedrijf opereert via de segmenten Physical Therapy Operations en Industrial Injury Prevention Services. Het bedrijf biedt pre- en postoperatieve zorg en behandeling voor orthopedische aandoeningen, sportblessures, preventieve zorg, revalidatie van gewonde werknemers en neurologische blessures.

U.S. Physical Therapy, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van U.S. Physical Therapy zich tot de beurswaarde?
UPH fundamentele statistieken
Marktkapitalisatie	€1.42b
Inkomsten(TTM)	€13.54m
Inkomsten(TTM)	€613.69m

104.7x

Koers/Winstverhouding

2.3x

P/S-verhouding

Is UPH overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
UPH resultatenrekening (TTM)
Inkomsten	US$639.06m
Kosten van inkomsten	US$513.20m
Brutowinst	US$125.86m
Overige uitgaven	US$111.76m
Inkomsten	US$14.10m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	0.93
Brutomarge	19.69%
Nettowinstmarge	2.21%
Schuld/Eigen Vermogen Verhouding	21.2%

Hoe presteerde UPH op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

1.8%

Huidig dividendrendement

187%

Uitbetalingsratio

Betaalt UPH een betrouwbaar dividend?

Zie UPH dividendgeschiedenis en benchmarks

Wanneer moet je UPH kopen om een aanstaand dividend te ontvangen?
U.S. Physical Therapy dividenddata
Ex Dividend Datum	Nov 15 2024
Betaaldatum dividend	Dec 06 2024
Dagen tot Ex-dividend	10 days
Dagen tot dividendbetaaldatum	11 days

Betaalt UPH een betrouwbaar dividend?

Zie UPH dividendgeschiedenis en benchmarks

UPH Overzicht aandelen

Beloningen

Risicoanalyse

U.S. Physical Therapy, Inc. Concurrenten

XTRA:RHK

€836.7m

XTRA:M12

€307.1m

XTRA:LIK

€99.7m

MUN:JTH

€24.4m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

President & COO recently sold €179k worth of stock

Third quarter dividend of US$0.44 announced

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

Recent updates

President & COO recently sold €179k worth of stock

Third quarter dividend of US$0.44 announced

Third quarter 2024 earnings released: EPS: US$0.39 (vs US$0.51 in 3Q 2023)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

Now 21% undervalued after recent price drop

Chairman & CEO recently sold €196k worth of stock

Chief Operating Officer - East recently sold €242k worth of stock

First quarter dividend of US$0.44 announced

First quarter 2024 earnings released: EPS: US$0.54 (vs US$0.58 in 1Q 2023)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Chief Operating Officer - West recently sold €253k worth of stock

Fourth quarter dividend of US$0.44 announced

New minor risk - Profit margin trend

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: US$1.99 (vs US$2.25 in FY 2022)

Now 21% undervalued

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Now 21% undervalued after recent price drop

Third quarter 2023 earnings released: EPS: US$0.62 (vs US$0.72 in 3Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Chief Operating Officer - West recently sold €413k worth of stock

Second quarter 2023 earnings released: EPS: US$0.80 (vs US$0.87 in 2Q 2022)

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

First quarter 2023 earnings released: EPS: US$0.57 (vs US$0.67 in 1Q 2022)

Independent Director recently sold €439k worth of stock

Executive VP recently sold €87k worth of stock

Upcoming dividend of US$0.43 per share at 1.7% yield

Full year 2022 earnings released: EPS: US$2.25 (vs US$2.42 in FY 2021)

U.S. Physical Therapy, Inc. to Report Q4, 2022 Results on Feb 22, 2023

Independent Director recently sold €573k worth of stock

President recently sold €858k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice from practice’s owners for $25 million.

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Thirteen-clinic physical therapy practice for $25 million.

Insufficient new directors

Upcoming dividend of US$0.41 per share

Chief Operating Officer - West recently sold €162k worth of stock

Now 23% undervalued after recent price drop

Third quarter 2022 earnings released: EPS: US$0.73 (vs US$0.66 in 3Q 2021)

U.S. Physical Therapy, Inc. Provides Operating Guidance for 2022

U.S. Physical Therapy, Inc. (NYSE : USPH) acquired 60% stake in Fourteen-clinic physical therapy practice for $19.3 million.

U.S. Physical Therapy, Inc. to Report Q3, 2022 Results on Nov 03, 2022

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 80% stake in Two-Clinic Physical Therapy Practice for $4.2 million.

Director recently bought €78k worth of stock

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in six-clinic physical therapy practice in West Virginia and Pennsylvania for $3.5 million.

Independent Director recently bought €82k worth of stock